IPO registrations (S-1, F-1) · Registrants
INTROGEN THERAPEUTICS INC
- SEC CIK
- 1018710 · filings on EDGAR ↗
- Registration
- Form S-1, first filed 1996-09-03, last 2000-10-11; 2 initial registrations, 9 amendments
- Outcome
- Final prospectus filed 2000-10-12; withdrawal requested 1996-10-28
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Business address
- 301 CONGRESS AVE, SUITE 1850, Austin, TX 78701
- EIN
- 74-2704230
- EDGAR entity type
- operating
- Insiders and CEO pay
- INTROGEN THERAPEUTICS INC on the corporate pages
Offering terms
- Proposed price range
- $8.00–$10.00 per share (S-1/A filed 2000-10-11)
- Final price
- $8.00 per share, within the range (424B4 filed 2000-10-12, an initial public offering)
- Shares sold
- 4,000,000
- Gross proceeds
- $32,000,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol INGN
- Lead underwriters
- Cowen (1,604,800 shares)
- Syndicate
- PaineWebber (802,400); Prudential Securities (802,400); ABN AMRO (60,800); J.P. Morgan (60,800); CIBC World Markets (60,800); ING Barings LLC (60,800); Lehman Brothers (60,800); Nomura (60,800); Piper Sandler (60,800); Citigroup (60,800); UBS (60,800); Fahnestock & Co. Inc (30,400); Gerard Klauer Mattison & Co., LLC (30,400); Gruntal & Co., L.L.C (30,400); Janney Montgomery Scott (30,400); Raymond James (30,400); Sanders Morris Harris (30,400); Tucker Anthony Incorporated (30,400); First Security Van Kasper (30,400)
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Lobbying client: INTROGEN THERAPEUTICS INC Fuzzy (name and state)
- SEC filer: INTROGEN THERAPEUTICS INC EXACT (CIK (EXACT))
- Person page: John N Kapoor Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
Filings 15
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 1996-09-03 | S-1 | S-1 (registration) | INTROGEN THERAPEUTICS INC | 0000950123-96-004842 ↗ |
| 1996-10-15 | S-1/A | S-1/A (amendment) | INTROGEN THERAPEUTICS INC | 0000950123-96-005601 ↗ |
| 1996-10-28 | RW | RW (withdrawal request) | INTROGEN THERAPEUTICS INC | 0000891618-96-002413 ↗ |
| 1996-10-28 | S-1/A | S-1/A (amendment) | INTROGEN THERAPEUTICS INC | 0000891618-96-002415 ↗ |
| 1996-11-01 | S-1/A | S-1/A (amendment) | INTROGEN THERAPEUTICS INC | 0000891618-96-002484 ↗ |
| 1996-11-08 | S-1/A | S-1/A (amendment) | INTROGEN THERAPEUTICS INC | 0000891618-96-002580 ↗ |
| 1996-11-12 | S-1/A | S-1/A (amendment) | INTROGEN THERAPEUTICS INC | 0000891618-96-002621 ↗ |
| 1996-12-03 | RW | RW (withdrawal request) | INTROGEN THERAPEUTICS INC | 0000891618-96-002967 ↗ |
| 1996-12-05 | RW | RW (withdrawal request) | INTROGEN THERAPEUTICS INC | 0000891618-96-002983 ↗ |
| 2000-02-17 | S-1 | S-1 (registration) | INTROGEN THERAPEUTICS INC | 0000950129-00-000689 ↗ |
| 2000-08-02 | S-1/A | S-1/A (amendment) | INTROGEN THERAPEUTICS INC | 0000950129-00-003915 ↗ |
| 2000-09-08 | S-1/A | S-1/A (amendment) | INTROGEN THERAPEUTICS INC | 0000950129-00-004536 ↗ |
| 2000-10-04 | S-1/A | S-1/A (amendment) | INTROGEN THERAPEUTICS INC | 0000950129-00-004850 ↗ |
| 2000-10-11 | S-1/A | S-1/A (amendment) | INTROGEN THERAPEUTICS INC | 0000950129-00-004932 ↗ |
| 2000-10-12 | 424B4 | 424B4 (final prospectus) | INTROGEN THERAPEUTICS INC | 0000950129-00-004961 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2000-10-11 | S-1/A | registration statement | $8.00–$10.00 | 4,000,000 | - | Nasdaq INGN | 3 | primary document; range, price line, shares headline, proceeds computed, price outside the range dropped, cover names 3 | document ↗ | |
| 2000-10-12 | 424B4 | final prospectus | $8.00 | 4,000,000 | $32,000,000 | Nasdaq INGN | 20 | primary document; price sentence, shares headline, proceeds table, underwriting table 20, cover names 3 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| PARKER DAVID L | Officer | Senior Vice President; Sr. Vice President; Vice President | 6 | 2006–2008 | |
| ALBRECHT JAMES W JR | Officer; Other | CFO; Chief Executive Officer; Chief Financial Officer | 7 | 2006–2008 | |
| NANCE DAVID G | Director,Officer | CEO & Pres; CEO & President; Chief Executive Officer & Pres | 3 | 2006–2007 | |
| ENLOE J DAVID JR | Officer | Senior Vice President; Senior VP; Sr. Vice President; Sr. VP | 6 | 2006–2008 | |
| AVENTIS HOLDINGS INC | Other | 15 | 2006 | ||
| Aventis Inc. | Other | 16 | 2006 | ||
| CUNNINGHAM WILLIAM H DR | Director | 3 | 2006–2008 | ||
| GILLIS STEPHEN MALCOLM | Director | 5 | 2006–2009 | ||
| HUTT PETER BARTON | Director | 4 | 2006–2008 | ||
| KAPOOR JOHN N | Director | 4 | 2006–2008 | person page Fuzzy | |
| LONG CHARLES E | Director | 3 | 2006–2008 | ||
| SOBOL ROBERT E | Officer | Senior Vice President; Sr. Vice President | 4 | 2006–2008 | |
| TALBOTT MAX W | Officer | Senior Vice President; Sr. Vice President; St. Vice President | 4 | 2006–2008 | |
| Pearson Robert W. | Director | 3 | 2008 | ||
| Rothman James | Director | 2 | 2008 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Lobbying client | INTROGEN THERAPEUTICS INC | TX | Federal lobbying (LDA) | name and state |
| SEC filer | INTROGEN THERAPEUTICS INC | SEC filers (EDGAR) | CIK (EXACT) | |
| Person page | John N Kapoor | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Pharmaceutical Preparations, TX first:
- LEXICON PHARMACEUTICALS, INC. TX
- FILANA THERAPEUTICS, INC. TX
- Marker Therapeutics, Inc. TX
- TANOX INC TX
- LUMOS PHARMA, INC. TX
- BIO-PATH HOLDINGS, INC. TX
- Savara Inc TX
- Altrazeal Life Sciences Inc. TX
- Molecular Templates, Inc. TX
- PLX PHARMA INC. TX
In other datasets, the same topic (Health) in TX:
- Nonprofit: AARON ALEXANDERS CLUB NICU (Nonprofits (IRS Form 990))
Interests: Pharmaceutical Preparations · Health